Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
Show more...
首席执行官
员工
217
国家
US
上市
0 Comments
分享你的想法
FAQ
Harrow Health 11.875% Senior Notes due 2027 今天的股价是多少?▼
HROWM 当前价格为 $26.03 USD,在过去 24 小时内下跌了 -0.08%。在图表上更密切关注 Harrow Health 11.875% Senior Notes due 2027 股票的表现。
Harrow Health 11.875% Senior Notes due 2027 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Harrow Health 11.875% Senior Notes due 2027 的股票以代码 HROWM 进行交易。
Harrow Health 11.875% Senior Notes due 2027 的股价在上涨吗?▼
HROWM 股票较上周上涨 +0%,本月上涨 +0%,但过去一年 Harrow Health 11.875% Senior Notes due 2027 下跌 -0.19%。
Harrow Health 11.875% Senior Notes due 2027 去年的营收是多少?▼
Harrow Health 11.875% Senior Notes due 2027 去年的营收为 199.61MUSD。
Harrow Health 11.875% Senior Notes due 2027 去年的净利润是多少?▼
HROWM 去年的净收益为 -17.48MUSD。
Harrow Health 11.875% Senior Notes due 2027 会发放股息吗?▼